Abstract: Intravenous anaesthetic drugs are the primary means for producing general anaesthesia in equine practice. The ideal drug for intravenous anaesthesia has high reliability and pharmacokinetic properties indicating short elimination and lack of accumulation when administered for prolonged periods. Induction of general anaesthesia with racemic ketamine preceded by profound sedation has already an established place in the equine field anaesthesia. Due to potential advantages over racemic ketamine, S-ketamine has been employed in horses to induce general anaesthesia, but its optimal dose remains under investigation. The objective of this study was to evaluate whether 2.5 mg/kg S-ketamine could be used as a single intravenous bolus to provide short-term surgical anaesthesia in colts undergoing surgical castration, and to report its pharmacokinetic profile. Results: After premedication with romifidine and L-methadone, the combination of S-ketamine and diazepam allowed reaching surgical anaesthesia in the 28 colts. Induction of anaesthesia as well as recovery were good to excellent in the majority (n = 22 and 24, respectively) of the colts. Seven horses required additional administration of S-ketamine to prolong the duration of surgical anaesthesia. Redosing did not compromise recovery quality. Plasma concentration of S-ketamine decreased rapidly after administration, following a two-compartmental model, leading to the hypothesis of a consistent unchanged elimination of the parent compound into the urine beside its conversion to S-norketamine. The observed plasma concentrations of S-ketamine at the time of first movement were various and did not support the definition of a clear cut-off value to predict the termination of the drug effect. Conclusions: The administration of 2.5 mg/kg IV S-ketamine after adequate premedication provided good quality of induction and recovery and a duration of action similar to what has been reported for racemic ketamine at the dose of 2.2 mg/kg. Until further investigations will be provided, close monitoring to adapt drug delivery is mandatory, particularly once the first 10 minutes after injection are elapsed. Taking into account rapid elimination of S-ketamine, significant inter-individual variability and rapid loss of effect over a narrow range of concentrations a sudden return of consciousness has to be foreseen.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study investigates the effectiveness of using an intravenous dose of 2.5mg/kg S-ketamine for general anaesthesia in horses during field castration, and the associated pharmacokinetic profile. It concluded that this dosage provided good induction and recovery and a duration of action close to that of racemic ketamine.
Research Objectives and Methodology
The goal of the study was to ascertain if S-ketamine could provide short-term surgical anaesthesia for horses undergoing field castration with a single 2.5 mg/kg IV dose.
The research team also aimed to study the pharmacokinetic profile of S-ketamine, focusing on the onset, duration, and end of the anaesthetic effect.
The study involved 28 colts, each premedicated with romifidine and L-methadone. After this premedication, S-ketamine and diazepam were used to induce general anaesthesia.
Findings of Study
Most of the colts (22 and 24, respectively) showed good to excellent induction of anaesthesia and recovery.
Additional administration of S-ketamine was required in seven horses to prolong the surgical anaesthesia duration, without compromising recovery quality.
Plasma concentration of S-ketamine fell quickly after administration, suggesting the substance is quickly transformed into S-norketamine and eliminated via urine.
The study could not identify a clear cut-off value to predict termination of S-ketamine’s drug effect, as plasma concentrations were varied.
Conclusions
The administration of 2.5 mg/kg IV S-ketamine after adequate premedication resulted in good induction and recovery quality, similar to that achieved with racemic ketamine at the dose of 2.2 mg/kg.
Due to the rapid elimination of S-ketamine and the determination that its efficiency differs significantly among individuals, it’s critical to monitor the patient meticulously, especially after the first 10 minutes post-injection.
Given the fast loss of S-ketamine’s effect at a narrow range of concentrations, an abrupt return of consciousness should be expected.
Cite This Article
APA
Casoni D, Spadavecchia C, Wampfler B, Thormann W, Levionnois OL.
(2015).
Clinical and pharmacokinetic evaluation of S-ketamine for intravenous general anaesthesia in horses undergoing field castration.
Acta Vet Scand, 57(1), 21.
https://doi.org/10.1186/s13028-015-0112-4
Anesthesiology and Pain Therapy Division, Department of Veterinary Clinical Science of the Vetsuisse Faculty of Berne, Länggassstrasse 124, CH-3012, Berne, Switzerland. daniela.casoni@vetsuisse.unibe.ch.
Spadavecchia, Claudia
Anesthesiology and Pain Therapy Division, Department of Veterinary Clinical Science of the Vetsuisse Faculty of Berne, Länggassstrasse 124, CH-3012, Berne, Switzerland. claudia.spadavecchia@vetsuisse.unibe.ch.
Clinical Pharmacology Laboratory, Institute for Infectious Diseases, University of Berne, Murtenstrasse 35, CH-3010, Bern, Switzerland. wolfgang.thormann@ifik.unibe.ch.
Levionnois, Olivier L
Anesthesiology and Pain Therapy Division, Department of Veterinary Clinical Science of the Vetsuisse Faculty of Berne, Länggassstrasse 124, CH-3012, Berne, Switzerland. olivier.levionnois@vetsuisse.unibe.ch.
Deleforge J, Davot JL, Boisrame B, Delatour P. Enantioselectivity in the anaesthetic effect of ketamine in dogs.. J Vet Pharmacol Ther 1991 Dec;14(4):418-20.
Engelhardt W, Stahl K, Marouche A, Hartung E. [Recovery time after (S)-ketamine or ketamine racemate. Recovery time after short anesthesia in volunteers].. Anaesthesist 1998 Mar;47(3):184-92.
Larenza MP, Althaus H, Conrot A, Balmer C, Schatzmann U, Bettschart-Wolfensberger R. Anaesthesia recovery quality after racemic ketamine or S-ketamine administration to male cats undergoing neutering surgery.. Schweiz Arch Tierheilkd 2008 Dec;150(12):599-607.
Marietta MP, WAY WL, Castagnoli N Jr, Trevor AJ. On the pharmacology of the ketamine enantiomorphs in the rat.. J Pharmacol Exp Ther 1977 Jul;202(1):157-65.
Duque JC, Oleskovicz N, Guirro EC, Valadão CA, Soares VE. Relative potency of ketamine and S(+)-ketamine in dogs.. J Vet Pharmacol Ther 2008 Aug;31(4):344-8.
Casoni D, Spadavecchia C, Adami C. S-ketamine versus racemic ketamine in dogs: their relative potency as induction agents.. Vet Anaesth Analg 2015 May;42(3):250-9.
Bergadano A, Andersen OK, Arendt-Nielsen L, Theurillat R, Thormann W, Spadavecchia C. Plasma levels of a low-dose constant-rate-infusion of ketamine and its effect on single and repeated nociceptive stimuli in conscious dogs.. Vet J 2009 Nov;182(2):252-60.
Geisslinger G, Hering W, Thomann P, Knoll R, Kamp HD, Brune K. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.. Br J Anaesth 1993 Jun;70(6):666-71.
White M, de Graaff P, Renshof B, van Kan E, Dzoljic M. Pharmacokinetics of S(+) ketamine derived from target controlled infusion.. Br J Anaesth 2006 Mar;96(3):330-4.
Herd DW, Anderson BJ, Holford NH. Modeling the norketamine metabolite in children and the implications for analgesia.. Paediatr Anaesth 2007 Sep;17(9):831-40.
Zhao X, Venkata SL, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, Zarate CA Jr, Mager DE, Wainer IW. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.. Br J Clin Pharmacol 2012 Aug;74(2):304-14.
Chen J, Zou X, Hu B, Yang Y, Wang F, Zhou Q, Shen M. Effect of different doses of esketamine compared with fentanyl combined with propofol on hypotension in patients undergoing painless abortion surgery: a prospective, randomized, double-blind controlled clinical trial. BMC Anesthesiol 2022 Sep 28;22(1):305.
Liao YQ, Ma J, He Y, Su YW, Xu MZ, Zhang MQ. Preoperative sedation with intravenous S-ketamine versus midazolam in preschool children: a randomized controlled trial. BMC Anesthesiol 2025 Nov 21;25(1):582.
Liu Y, Gong Z, Zhang L, Yang X, Zhu J, Zhou X, Liao X. Esketamine attenuates traumatic brain injury by modulating STAT3-mediated Glycolysis and immune responses. BMC Neurosci 2025 Mar 7;26(1):21.
Helal IE, Al-Abbadi HA, Hashem MA, Abdelrazek HMA, Shekidef MH, Ahmed MF. Analgesic Effect of Dexmedetomidine-Nalbuphine Combination vs. Dexmedetomidine Alone in Donkeys Undergoing Field Castration under Total Intravenous Anesthesia. Animals (Basel) 2024 Aug 23;14(17).
Si J, Li X, Wang Y, Feng N, Cui M. Effects of adding low-dose esketamine to sufentanil and propofol sedation during cervical conization: a single-centre, randomized controlled trial. BMC Anesthesiol 2024 Jan 4;24(1):15.